Meridian Bioscience has developed a novel SARS-CoV-2 nucleocapsid monoclonal antibody pair that detects the conserved SARS-CoV-2 nucleoprotein domain highly specifically and does not cross-react with seasonal coronavirus strains. This pair of antibodies can be used to develop reliable rapid antigen
Cafsac mnliajq ip ksf iunq gzimotjmmkk sy yjkqr oli dofocst hu cmt.mzbzgrn.fy.